CDEK
← All drugs Report issue

canola oil

Botanicalexperimental

Rapeseed oil is one of the oldest known vegetable oils. There are both edible and industrial forms produced from rapeseed, the seed of several cultivars of the plant family Brassicaceae. Historically, it was restricted as a food oil due to its content of erucic acid. Laboratory studies about this acid have shown damage to the cardiac muscle of laboratory animals in high quantities. It also imparts a bitter taste, and glucosinolates, which made many parts of the plant less nutritious in animal feed. Rapeseed oil from standard cultivars can contain up to 54% erucic acid. — Wikipedia

Clinical trial activity

21 trials · 39 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
1

Earliest trial started Sep 1, 1997 (NCT00560014)

Timeline

2000s

  1. Jan 1, 2002

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetSupplementation

    supplementation

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • canola oil
  • canola oil
  • oils, glyceridic, canola
  • rapeseed oil
  • rapeseed oil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07289880N/ADec 30, 2025Guangdong Pharmaceutical University
NCT06640036N/AOct 1, 2024Chalmers University of Technology, University of Gothenburg
NCT05271045N/ADec 1, 2021National Nutrition and Food Technology Institute
NCT04209244N/ADec 16, 2019Danish Child Cancer Foundation, University of Copenhagen
NCT04024605N/AJan 15, 2019AgroParisTech, Government of France
NCT03596346N/AJul 4, 2018Avena Nordic Grain Oy, Satucon Oy
NCT03438084N/AMay 1, 2018University of London
NCT03191513N/AJun 12, 2017University of London
NCT04867629N/AJul 31, 2015University of Glasgow
NCT01890330N/AJul 31, 2013Canola Council of Canada, University of Manitoba
NCT02029833N/AMar 31, 2013Agriculture and Agri-Food Canada, Canola Council of Canada, Laval University, Pennsylvania State University, University at Buffalo, University of Manitoba, University of Toronto
NCT01683565Phase 4Sep 1, 2012Ohio State University
NCT01577628N/AJun 1, 2012Cosmetique Active International, Innovaderm
NCT00924339N/ASep 1, 2009University of Vienna
NCT01067911N/AJul 1, 2009Flax Council of Canada, University of British Columbia
NCT00852735N/ADec 1, 2008Government of France, Institut technique d'études et de recherches des corps gras, Lesieur, Unilever, University Clermont Auvergne
NCT00924274N/AMar 1, 2008University of Vienna
NCT03025620N/ANov 1, 2006Institut Elevage, Institut technique d'études et de recherches des corps gras, TERRES INOVIA, University of Paris
NCT01119690N/ASep 1, 2004Central Hospital of Kanta-Hame, Finnish Red Cross, Linnan Klinikka Oy, MTT Agrifood Research Finland
NCT00047983Early Phase 1 (Phase 1)Oct 23, 2002National Institute of Allergy and Infectious Diseases (NIAID), University of Cincinnati
Showing 20 of 21 trials
Page 1 / 2

Organizations

Research & Development (39)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Canola Council of CanadaAcademic/Hospital2012013
Government of FranceGovernment2112008
Institut technique d'études et de recherches des corps grasAcademic/Hospital2012006
University of CincinnatiAcademic/Hospital2121997
University of LondonAcademic/Hospital2212017
University of ManitobaAcademic/Hospital2212013
University of ViennaAcademic/Hospital2212008
Agriculture and Agri-Food CanadaGovernment1012013
AgroParisTechAcademic/Hospital1012019
Avena Nordic Grain OyFor profit1112018
Central Hospital of Kanta-HameAcademic/Hospital1112004
Chalmers University of TechnologyAcademic/Hospital1012024
Cosmetique Active InternationalFor profit1112012
Danish Child Cancer FoundationAcademic/Hospital1012019
Finnish Red CrossAcademic/Hospital1012004
Flax Council of CanadaAcademic/Hospital1012009
Guangdong Pharmaceutical UniversityAcademic/Hospital1112025
InnovadermFor profit1012012
Institut ElevageAcademic/Hospital1012006
Laval UniversityAcademic/Hospital1012013
39 organizations
Page 1 / 2